"I used to see him walking to me with the injection and I was like, 'I just cannot deal with this anymore. I don't know how I ...

Mayim Bialik is speaking out candidly about a severe reaction she says she experienced after taking a GLP-1 medication, revealing that a single low-dose injection led to weeks of debilitating ...

(NEXSTAR) – GLP-1 drugs, which have grown incredibly popular in recent years for their ability to help people lose substantial weight, are now friendlier to needle-phobes. The class of medications, ...

In a sweeping analysis of more than 400,000 Reddit posts, researchers have revealed some little-known GLP-1 side effects. GLP-1 receptor agonists — such as semaglutide (Ozempic and Wegovy), and ...

Osteoarthritis affects around 600 million people globally. It causes pain, stiffness and reduced joint function – most commonly in the knees, hands and hips. There’s currently no cure for ...

If you've been following the weight-loss medication revolution, you've likely heard about Wegovy injections. But now there's a new option that might be even more appealing: a once-daily pill. The FDA ...

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

More common side effects of Yeztugo include injection site reactions, headache, and nausea. Yeztugo has a boxed warning about the risk of drug resistance when used in people with undiagnosed HIV. If ...

A massive review of 23 randomized trials found that statins do not cause the vast majority of side effects listed on their labels. Memory problems, depression, sleep issues, weight gain, and many ...

Germany Progesterone Injection Market: Key Market Drivers The market growth is significantly propelled by digital transformation initiatives, with automation trends streamlining manufacturing ...

Recent technological advancements are revolutionizing the United States progesterone injection landscape, emphasizing precision, safety, and patient-centricity. Innovations such as ...

On December 22, 2025, the U.S. Food and Drug Administration (FDA) approved an oral pill form of Wegovy — a glucagon-like peptide-1 (GLP-1) receptor agonist medication for weight loss. Until now, ...